Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.5K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.1K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.1K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

5.0K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
5.0K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
GTPases and their Regulation02:14

GTPases and their Regulation

9.8K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.8K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.8K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Neuropeptide Y in cancer metastasis and chemoresistance.

Neuropeptides·2026
Same author

Publisher Correction: CRISPR activation for SCN2A-related neurodevelopmental disorders.

Nature·2025
Same author

The nervous system in prostate cancer: A basic science and clinical perspective.

Seminars in oncology·2025
Same author

Correction: Editorial: Current status and recent advances in preclinical models for rare cancers.

Frontiers in oncology·2025
Same author

CRISPR activation for SCN2A-related neurodevelopmental disorders.

Nature·2025
Same author

Editorial: Current status and recent advances in preclinical models for rare cancers.

Frontiers in oncology·2025

Related Experiment Video

Updated: Feb 1, 2026

Studying the Activity of Neuropeptides and Other Regulators of the Excretory System in the Adult Mosquito
11:30

Studying the Activity of Neuropeptides and Other Regulators of the Excretory System in the Adult Mosquito

Published on: August 24, 2021

3.3K

Neuropeptide Y receptor interactions regulate its mitogenic activity.

Magdalena Czarnecka1, Congyi Lu2, Jennifer Pons1

  • 1Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, DC, USA.

Neuropeptides
|December 4, 2018
PubMed
Summary
This summary is machine-generated.

Neuropeptide Y (NPY) receptors, Y1R, Y2R, and Y5R, form dimers that amplify NPY

Keywords:
G protein-coupled receptorsHeterodimerizationHomodimerizationNeuropeptide YProliferation

More Related Videos

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

12.0K
Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

9.2K

Related Experiment Videos

Last Updated: Feb 1, 2026

Studying the Activity of Neuropeptides and Other Regulators of the Excretory System in the Adult Mosquito
11:30

Studying the Activity of Neuropeptides and Other Regulators of the Excretory System in the Adult Mosquito

Published on: August 24, 2021

3.3K
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

12.0K
Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

9.2K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Neuropeptide Y (NPY) is a neurotransmitter that regulates various physiological functions through G protein-coupled receptors: Y1R, Y2R, and Y5R.
  • NPY's proliferative effects are mediated by these receptors, which can dimerize, but the functional significance of receptor interplay remains unclear.
  • Understanding NPY receptor interactions is crucial for developing targeted therapies.

Purpose of the Study:

  • To identify Neuropeptide Y (NPY) receptor interactions, specifically in the ligand-binding fraction.
  • To determine the impact of these receptor interactions on the mitogenic activity of NPY.

Main Methods:

  • Expression of Y1R, Y2R, and Y5R in CHO-K1 cells.
  • Detection of receptor homodimers and heterodimers using cell surface cross-linking.
  • Assessment of NPY-induced proliferation and receptor internalization.

Main Results:

  • Y1R, Y2R, and Y5R formed homodimers on the cell surface.
  • Y1R and Y5R heterodimerized; Y2R/Y5R heterodimers were not detected.
  • Y5R transactivation occurred upon stimulation of co-expressed receptors, leading to augmented mitogenic responses at lower NPY concentrations.

Conclusions:

  • Direct and indirect heterotypic Neuropeptide Y (NPY) receptor interactions amplify NPY's mitogenic activity.
  • These findings are critical for designing novel therapeutic strategies targeting the NPY system.